Nano-X Imaging Ltd. (NNOX)
Pre-market:
| Previous close | 11.43 |
| Open | 11.47 |
| Bid | 0.00 x 1100 |
| Ask | 0.00 x 1300 |
| Day's range | 11.45 - 12.47 |
| 52-week range | 8.23 - 28.60 |
| Volume | |
| Avg. volume | 428,688 |
| Market cap | 598.903M |
| Beta (5Y monthly) | 1.72 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.43 |
| Earnings date | 15 Nov 2022 - 21 Nov 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 36.75 |
- Motley Fool
Here's Why Nanox Stock Soared on Wednesday
Shares of Nano-X Imaging (NASDAQ: NNOX), commonly called Nanox, soared on Wednesday after it revealed it's taken the next step toward commercializing its flagship medical device. As of 12:20 p.m. ET, Nanox stock was up 21%. Nanox had its initial public offering (IPO) in 2020, promising to disrupt the X-ray industry with its digital-3D imaging machines that will be cheaper for doctors to use.
- Motley Fool
3 Stocks to Buy and Hold for the Long Term
One of the big advantages individual investors have over fund managers is that no one is looking over their shoulders for quick results. In this roundtable, three Motley Fool contributors picked healthcare stocks that they believe will be big winners for a long time. Here's why they recommend OrthoPediatrics (NASDAQ: KIDS), Compass Pathways (NASDAQ: CMPS), and Nano-X Imaging (NASDAQ: NNOX).
- Motley Fool
Nano-X Imaging Ltd. (NNOX) Q2 2022 Earnings Call Transcript
Earlier today, Nano-X Imaging Limited released its financial results for the quarter ended June 30, 2022. Erez Meltzer, chief executive officer; and Ran Daniel, chief financial officer, will host this morning's call. Before we get started, I would like to remind everyone that management will be making statements during this call that include forward-looking statements regarding the company's financial results, research and development, manufacturing and commercialization activities, regulatory process operations, and other matters.
